In our study we develop a preparation of the 1G8 antibody that specifically recognizes MUC4β by immunoblotting, and whose immunoreactivity with cultured MUC4-positive breast cancer cells by immunohistochemical staining is markedly suppressed when MUC4 expression is knocked down. This evidence concerns the gene MUC4 and breast cancer.